Thomas H. Connor

Statistics

Publications

Citations

2.7K

H-Index

Active since

1975

Affiliations

The University of Texas Health Science Center at Houston(Current)

National Institute for Occupational Safety and Health

The University of Texas Medical Branch at Galveston

The University of Texas MD Anderson Cancer Center

Anderson Hospital

Thomas H. Connor is an author at The University of Texas Health Science Center at Houston specializing in pharmacy, toxicology, and mutagenicity assessment.

ORCID

Publications per year

1975–2022

Publications

Evaluation of Antineoplastic Drug Exposure of Health Care Workers at Three University-Based US Cancer Centers

Thomas H. Connor, D. Gayle DeBord, Jack R. Pretty et al. · Journal of Occupational and Environmental Medicine · 2010 · 233 citations

Pharmacy, Pharmacology, Toxicology +16

Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States

Thomas H. Connor, Roger W. Anderson, P.J.M. Sessink et al. · American Journal of Health-System Pharmacy · 1999 · 217 citations

Pharmacy, Oncology, Pharmaceutical Analysis +13

Detection of Mutagenic Activity of Metronidazole and Niridazole in Body Fluids of Humans and Mice

Marvin S. Legator, Thomas H. Connor, M.E. Stoeckel · Science · 1975 · 194 citations

Pharmacy, Pharmacology, Toxicology +10

NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2012

Thomas H. Connor, Barbara A. MacKenzie, D. Gayle DeBord et al. · 2012 · 177 citations

Pharmacy, Oncology, Pharmacology +15

Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device

P.J.M. Sessink, Thomas H. Connor, James A. Jorgenson et al. · Journal of Oncology Pharmacy Practice · 2010 · 157 citations

Pharmacy, Pharmacology, Pharmacy Practice +13

1–5 of 49